AVRO - Avrobio Inc. - Stock Price & Catalysts • BiopharmIQ

Enterprise Value

-5.916M

Cash

72.33M

Avg Qtr Burn

-22.37M

Short % of Float

2.56%

Insider Ownership

2.66%

Institutional Own.

52.87%

Qtr Updated

03/31/23

Drug Pipeline

Only showing assets and stage. See catalyst data with a free or premium account. Unlock more data with a free account.

Drug & Indication	Stage & Event	Catalyst Date
AVR-RD-02 Details Gaucher disease	Phase 2/3 Initiation	Some catalyst date You must sign up to see the catalyst details. You must sign up to see the catalyst details. You must sign up to see the catalyst details. You must sign up to see the catalyst details.Sign up now.
AVR-RD-04 Details Cystinosis	Phase 2 Update	Some catalyst date You must sign up to see the catalyst details. You must sign up to see the catalyst details. You must sign up to see the catalyst details. You must sign up to see the catalyst details.Sign up now.
AVR-RD-05 Details Mucopolysaccharidoses, Mucopolysaccharidosis type II, Rare diseases, Rare genetic disease, Genetic disorder	Phase 1/2 Data readout	Some catalyst date You must sign up to see the catalyst details. You must sign up to see the catalyst details. You must sign up to see the catalyst details. You must sign up to see the catalyst details.Sign up now.
AVR-RD-01 Details Genetic disorder, Fabry disease	Failed Discontinued	Some catalyst date You must sign up to see the catalyst details. You must sign up to see the catalyst details. You must sign up to see the catalyst details. You must sign up to see the catalyst details.Sign up now.